Literature DB >> 27215092

MiR-31 Functions as a Tumor Suppressor in Lung Adenocarcinoma Mainly by Targeting HuR.

Hai Xu, Jianqun Ma, Jian Zheng, Jun Wu, Changfa Qu, Fenglin Sun, Shidong Xu.   

Abstract

BACKGROUND: Gene expression is widely regulated by miRNAs and RNA binding proteins. In this study, we mainly focused on miR-31 and a RNA binding protein, HuR (Hu antigen R).
METHODS: The levels of miR-31 and HuR in lung carcinoma cells and lung cancer tissues were explored using RT-qPCR and western blot, respectively. Luciferase reporter assay was used to determine the target gene of miR-31. Cell apoptosis and migration were studied using flow cytometry and the transwell invasion assay. The down-stream genes of HuR were explored with western blot assay.
RESULTS: miR-31 was decreased in lung carcinoma cells and lung cancer tissues, while the protein level of HuR was increased. HuR was the target gene of miR-31. Inhibition of miR-31 and overexpression of HuR resulted in the upregulation of cyclins A2, B1, D1 and VEGF (vascular endothelial growth factor). Furthermore, overexpression of miR-31 prompted lung cancer cell apoptosis and inhibited cell migration.
CONCLUSIONS: Reduction of miR-31 expression enhanced lung cancer proliferation and migration by repressing HuR expression.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27215092     DOI: 10.7754/clin.lab.2015.150903

Source DB:  PubMed          Journal:  Clin Lab        ISSN: 1433-6510            Impact factor:   1.138


  9 in total

Review 1.  Drug delivery approaches for HuR-targeted therapy for lung cancer.

Authors:  Rajeswari Raguraman; Santny Shanmugarama; Meghna Mehta; Jo Elle Peterson; Yan D Zhao; Anupama Munshi; Rajagopal Ramesh
Journal:  Adv Drug Deliv Rev       Date:  2021-11-22       Impact factor: 15.470

2.  Identification of aminosulfonylarylisoxazole as microRNA-31 regulators.

Authors:  Kyungtaek Im; Jiho Song; Young Taek Han; Seul Lee; Soowon Kang; Kwang Woo Hwang; Hyeyoung Min; Kyung Hoon Min
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

Review 3.  Major Tumor Suppressor and Oncogenic Non-Coding RNAs: Clinical Relevance in Lung Cancer.

Authors:  Kentaro Inamura
Journal:  Cells       Date:  2017-05-09       Impact factor: 6.600

4.  Circulating miR-31 as an effective biomarker for detection and prognosis of human cancer: a meta-analysis.

Authors:  Yingjun Ma; Yunfang Chen; Jinbo Lin; Yi Liu; Kai Luo; Yong Cao; Tieqiang Wang; Hongwei Jin; Zhan Su; Haolin Wu; Xiaoliang Chen; Jinquan Cheng
Journal:  Oncotarget       Date:  2017-04-25

Review 5.  Oncogenic and tumor suppressive roles of special AT-rich sequence-binding protein.

Authors:  Qiao Yi Chen; Max Costa
Journal:  J Carcinog       Date:  2018-04-05

6.  Tissue microRNAs in non-small cell lung cancer detected with a new kind of liquid bead array detection system.

Authors:  Yuan-Yuan Zheng; Yun Fei; Zheng Wang; Yue Chen; Cheng Qiu; Fu-Rong Li
Journal:  J Transl Med       Date:  2020-03-02       Impact factor: 5.531

7.  Circular RNA circSATB2 promotes progression of non-small cell lung cancer cells.

Authors:  Nan Zhang; Aruo Nan; Lijian Chen; Xin Li; Yangyang Jia; Miaoyun Qiu; Xin Dai; Hanyu Zhou; Jialu Zhu; Han Zhang; Yiguo Jiang
Journal:  Mol Cancer       Date:  2020-06-03       Impact factor: 27.401

Review 8.  MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes.

Authors:  Cyril Sobolewski; Laurent Dubuquoy; Noémie Legrand
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

9.  MicroRNA-31 Regulates Expression of Wntless in Both Drosophila melanogaster and Human Oral Cancer Cells.

Authors:  Ji Eun Jung; Joo Young Lee; In Ryoung Kim; Sang Mee Park; Ji Wan Kang; Yun Hak Kim; Hae Ryoun Park; Ji Hye Lee
Journal:  Int J Mol Sci       Date:  2020-09-30       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.